Abstract
Background: Open-angle glaucoma (OAG) is one of the leading causes of blindness worldwide. This study evaluates the therapeutic effects of hab shabyar in patients with open-angle glaucoma. Materials and Methods: In this clinical randomized controlled trial, 50 patients with OAG were randomized into two groups. The intervention group received a drop of timolol plus 500 mg of hab shabyar every 12 hours. The placebo group received a drop of timolol every 12 hours plus 500 mg of wheat germ as a placebo. The intraocular pressure in patients with OAG was measured in each group and compared before the intervention (t1), one month (t2), and two months (t3) after the intervention. Results: The mean decrease in intraocular pressure for the right eye on three times in the intervention group was statistically significant, but the mean decrease in the placebo group was not significant. Similar results were obtained for the left eye at t1 when compared to t3. The intervention group patients expressed more satisfaction changes than the placebo group (P≤0.001). Conclusion: Our study demonstrated that consumption of timolol plus hab shabyar instead of consuming timolol alone was probably more effective for reducing intraocular pressure in patients with OAG.
Highlights
Open-angle glaucoma (OAG) is one of the most common types of glaucoma and one of the most common causes of blindness worldwide [1]
Considering that no randomized controlled trial to date has confirmed the effect of hab shabyar in the treatment of OAG, the present study was conducted to assess the efficiency of timolol plus hab shabyar compared to timolol alone in treating patients with OAG who were referred to clinics and educational, therapeutic hospitals affiliated with Tabriz University of Medical Sciences
50 confirmed cases with OAG were randomly allocated to the intervention and placebo groups
Summary
Open-angle glaucoma (OAG) is one of the most common types of glaucoma and one of the most common causes of blindness worldwide [1]. Khalil- BaniHabib E, et al. Therapeutic Effects of Hab Shabyar on Open-Angle Glaucoma groups in Japan [8], 1.8% in Australia [8], and 4.74% in California [9]. Considering that no randomized controlled trial to date has confirmed the effect of hab shabyar in the treatment of OAG, the present study was conducted to assess the efficiency of timolol plus hab shabyar compared to timolol alone (as a routine drug) in treating patients with OAG who were referred to clinics and educational, therapeutic hospitals affiliated with Tabriz University of Medical Sciences. This study evaluates the therapeutic effects of hab shabyar in patients with open-angle glaucoma. Conclusion: Our study demonstrated that consumption of timolol plus hab shabyar instead of consuming timolol alone was probably more effective for reducing intraocular pressure in patients with OAG. Conclusion: Our study demonstrated that consumption of timolol plus hab shabyar instead of consuming timolol alone was probably more effective for reducing intraocular pressure in patients with OAG. [GMJ.2020;9:e1218]
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
